Rapid cervical phIGFBP-1 test in asymptomatic twin pregnancies is inefficient in predicting preterm delivery prior to 34 gestational weeks

Ginekol Pol. 2018;89(6):321-325. doi: 10.5603/GP.a2018.0055.

Abstract

Objectives: To assess the effectiveness of a rapid second trimester test for cervical phIGFBP-1 in the prediction of sponta-neous preterm delivery prior to 34 weeks in asymptomatic twin pregnancies.

Material and methods: A prospective observational study conducted on 232 twin pregnancies tested for phIGFBP-1 at 20-24 weeks of gestation. 151 patients assessed as asymptomatic, with cervical length > 25 mm at 20-24 weeks were analysed. The primary outcome was the delivery < 34 weeks of gestation.

Results: The spontaneous preterm delivery before completing 34 weeks occurred in 23 patients (15.2%), including 9 in dichorionic and 14 in monochorionic pregnancies. The sensitivity of phIGFBP-1 test was 0.39 and specificity 0.63 in predicting delivery before 34 gestational weeks. phIGFBP-1 had a low positive predictive value of 0.16 and high negative predictive value (0.85). Both positive and negative predictive values of delivery < 34 weeks were close to 1.

Conclusions: A test for phIGFBP1 presence is not an effective additional tool for predicting preterm delivery before 34 weeks in twin gestation.

Keywords: IGFBP test; multiple gestation; preterm birth; preterm delivery screening tests; twin pregnancy.

MeSH terms

  • Adult
  • Cervix Uteri / metabolism*
  • Female
  • Humans
  • Insulin-Like Growth Factor Binding Protein 1 / metabolism*
  • Obstetric Labor, Premature / diagnosis*
  • Pregnancy
  • Pregnancy Trimester, Second / metabolism
  • Pregnancy, Twin / metabolism*
  • Premature Birth / diagnosis*
  • Prospective Studies
  • Risk Assessment
  • Young Adult

Substances

  • IGFBP1 protein, human
  • Insulin-Like Growth Factor Binding Protein 1